π¬
|
The hemostatic system.
J. Stassen,
J. Arnout,
H. Deckmyn
|
7 |
2004 |
7 π¬
|
π
|
Correlation between Oxidized Low Density Lipoproteins and von Willebrand Factor in Chronic Renal Failure
9 auth.
P. Holvoet,
J. Donck,
Michèle Landeloos,
E. Brouwers,
K. Luijtens,
J. Arnout,
...
E. Lesaffre,
Y. Vanrenterghem,
D. Collen
|
7 |
1996 |
7 π
|
π¬
|
Comparison of fresh frozen plasma and prothrombin complex concentrate for the reversal of oral anticoagulants in patients undergoing cardiopulmonary bypass surgery: a randomized study
R. Demeyere,
S. Gillardin,
J. Arnout,
P. Strengers
|
7 |
2010 |
7 π¬
|
π
|
Factor VIII Inhibitors in Previously Treated Haemophilia A Patients with a Double Virus-inactivated Plasma Derived Factor VIII Concentrate
8 auth.
K. Peerlinck,
J. Arnout,
M. Giambattista,
J. Gilles,
R. Laub,
M. Jacquemin,
...
J. SaintβRemy,
J. Vermylen
|
7 |
1997 |
7 π
|
π¦
|
The Pathogenesis of the Antiphospholipid Syndrome: a Hypothesis Based on Parallelisms with Heparin-induced Thrombocytopenia
J. Arnout
|
7 |
1996 |
7 π¦
|
π¬
|
PROLONGING PROSTACYCLIN PRODUCTION BY NAFAZATROM OR DIPYRIDAMOLE
H. Deckmyn,
P. Gresele,
J. Arnout,
A. Todisco,
J. Vermylen
|
7 |
1984 |
7 π¬
|
π¬
|
Dipyridamole Inhibits Platelet Aggregation in Whole Blood
P. Gresele,
C. Zoja,
H. Deckmyn,
J. Arnout,
J. Vermylen,
M. Verstraete
|
7 |
1983 |
7 π¬
|
π¦
|
Antiphospholipid Syndrome: Diagnostic Aspects of Lupus Anticoagulants
J. Arnout
|
7 |
2001 |
7 π¦
|
π
|
Tissue factor as the main activator of the coagulation system during cardiopulmonary bypass.
8 auth.
F. Somer,
Y. Belleghem,
F. Caes,
K. FranΓ§ois,
H. V. Overbeke,
J. Arnout,
...
Y. Taeymans,
G. Nooten
|
6 |
2002 |
6 π
|
π¦
|
Current status and implications of autoimmune antiphospholipid antibodies in relation to thrombotic disease
J. Arnout,
J. Vermylen
|
6 |
2003 |
6 π¦
|